Linc‐ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR‐194‐3p targeting MECP2

linc‐ROR is reported to be a potential biomarker of breast cancer, but the detailed mechanism of linc‐ROR‐mediated breast cancer regulation has not been fully studied. We aimed to explore how linc‐ROR affects proliferation, metastasis, and drug sensitivity in breast cancer. Cell lines in which linc‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Guo, Juan, Huang, Wenjie, Yu, Xiaosi, Xu, Chen, Long, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463371/
https://www.ncbi.nlm.nih.gov/pubmed/32335998
http://dx.doi.org/10.1002/1878-0261.12700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463371/
https://www.ncbi.nlm.nih.gov/pubmed/32335998
http://dx.doi.org/10.1002/1878-0261.12700

Ejemplares similares